精神疾病跨诊断的脑成像研究

注册号:

Registration number:

ChiCTR-BOC-17014001 

最近更新日期:

Date of Last Refreshed on:

2017-12-17 13:53:36 

注册时间:

Date of Registration:

2017-12-17 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

精神疾病跨诊断的脑成像研究

Public title:

Brain imaging studies in cross diagnostic groups

注册题目简写:

English Acronym:

研究课题的正式科学名称:

抑郁症、双相障碍与精神分裂症患者的脑成像研究

Scientific title:

Brain imaging studies in cross diagnostic groups

研究课题代号(代码):

Study subject ID:

国家自然科学基金(81571317, 31400884),北京市科学与技术领军人才项目(Z151100000315020),北京市科学与技术基金(Z161100000216138)

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王毅 

研究负责人:

陈楚侨 

Applicant:

Yi Wang 

Study leader:

Raymond Chan 

申请注册联系人电话:

Applicant telephone:

+86 010 64877349

研究负责人电话:

Study leader's
telephone:

+86 010 64836274

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wangyi@psych.ac.cn

研究负责人电子邮件:

Study leader's E-mail:

rckchan@psych.ac.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市朝阳区林萃路16号院

研究负责人通讯地址:

北京市朝阳区林萃路16号院

Applicant address:

16 Lincui Road, Chaoyang District, Beijing, China

Study leader's address:

16 Lincui Road, Chaoyang District, Beijing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国科学院心理研究所

Applicant's institution:

Institute of Psychology, Chinese Academy of Sciences

研究负责人所在单位:

中国科学院心理研究所

Affiliation of the Leader:

Institute of Psychology, Chinese Academy of Sciences

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2014-30

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

北京大学第六医院(精神卫生研究所)医学伦理委员会

Name of the ethic committee:

Peking University Sixth Hospital (Institute of Mental Health) Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

王雪芹

Contact Name of the ethic committee:

Xueqin Wang

伦理委员会联系地址:

北京市海淀区花园北路51号

Contact Address of the ethic committee:

51 Huayuan Road North, Haidian District, Beijing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中国科学院心理研究所

Primary sponsor:

Institute of Psychology, Chinese Academy of Sciences

研究实施负责(组长)单位地址:

北京朝阳区林萃路16号

Primary sponsor's address:

16 Lincui Road, Chaoyang District, Beijing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

中国科学院心理研究所

具体地址:

北京朝阳区林萃路16号

Institution
hospital:

Institute of Psychology, Chinese Academy of Sciences

Address:

16 Lincui Road, Chaoyang District, Beijing, China

经费或物资来源:

国家自然科学基金(81571317, 31400884),北京市科学与技术领军人才项目(Z151100000315020),北京市科学与技术基金(Z161100000216138)

Source(s) of funding:

National Natural Science Foundation of China (81571317, 31400884), Beijing Municipal Science and Technology Grants(Z151100000315020,Z161100000216138)

研究疾病:

抑郁症,双相障碍,精神分裂症  

Target disease:

Major Depressive disorder, Bipolar Disorder, Schizophrenia

研究疾病代码:

Target disease code:

研究类型:

57

Study type:

57

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

考察精神疾病,包括抑郁症、双相障碍和精神分裂症患者的脑结构和脑功能。  

Objectives of Study:

Examine the brain structure and brain function in mental disorders including major depressive disorder, bipolar disorder and schizophrenia.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.脑器质性疾病或其它有临床意义的并发躯体疾病
2.头部外伤史,意识丧失超过1小时;或明显智力低下
3.当前(3个月内)有酒精和药物滥用或有既往依赖史
4.脑成像测试还需要排除体内存有金属、幽闭恐惧症等

Exclusion criteria:

1. Physical condition;
2. Brain injury, IQ < 70;
3. History of substance abuse;
4. Mental implants in the body.

研究实施时间:

Study execute time:

From 2015-01-01 00:00:00 To 2020-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2016-09-01 00:00:00 To 2020-12-31 00:00:00

干预措施:

Interventions:

组别:

精神分裂症

样本量:

60

Group:

Schizophrenia

Sample size:

干预措施:

脑成像扫描

干预措施代码:

Intervention:

Brain imaging

Intervention code:

组别:

抑郁症

样本量:

60

Group:

Major Depressive disorder

Sample size:

干预措施:

脑成像扫描

干预措施代码:

Intervention:

Brain imaging

Intervention code:

组别:

双相障碍

样本量:

60

Group:

Bipolar Disorder

Sample size:

干预措施:

脑成像扫描

干预措施代码:

Intervention:

Brain imaging

Intervention code:

组别:

健康对照组

样本量:

60

Group:

Healthy Control

Sample size:

干预措施:

脑成像扫描

干预措施代码:

Intervention:

Brain imaging

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京大学第六医院 

单位级别:

三级甲等 

Institution
hospital:

Peking University Sixth Hospital

Level of the institution:

Tertiary A hospital

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京安定医院 

单位级别:

三级甲等 

Institution
hospital:

Beijing Anding Hospital of Capital Medical University

Level of the institution:

Tertiary A hospital

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京朝阳医院 

单位级别:

三级甲等 

Institution
hospital:

Beijing Chao-Yang Hospital,Capital Medical University

Level of the institution:

Tertiary A hospital

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京市海淀区精神卫生防治院 

单位级别:

二级甲等 

Institution
hospital:

Haidian District Mental Health Center

Level of the institution:

Secondary A hospital

国家:

中国

省(直辖市):

黑龙江 

市(区县):

 

Country:

China

Province:

Heilongjiang

City:

单位(医院):

齐齐哈尔市精神卫生中心 

单位级别:

二级甲等 

Institution
hospital:

Qiqihaer Mental Health Center

Level of the institution:

Secondary A hospital

测量指标:

Outcomes:

指标中文名:

灰质体积

指标类型:

主要指标

Outcome:

gray matter volume

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

功能连接

指标类型:

主要指标

Outcome:

functional connectivity

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

临床症状

指标类型:

主要指标

Outcome:

clinical symptoms

Type:

Primary indicator

测量时间点:

测量方法:

PANSS, HAMD, YMRS

Measure time point of outcome:

Measure method:

指标中文名:

认知功能

指标类型:

主要指标

Outcome:

cognition

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

脑影像

组织:

Sample Name:

brain images

Tissue:

人体标本去向

使用后保存  

说明

Fate of sample:

Preservation after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

计算机随机数字法

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number generated by computer

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

原始数据仅在中国科学院心理研究所内部数据库共享。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Data is only shared within the internal database of the Institute of Psychology of CAS .

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

通过病例记录表和功能磁共振扫描系统采集和管理数据。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data is collected and managed through CRF and fMRI scanning system.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2017-12-17 13:53:36